About
We aim to optimize recognition of genetic tumor risk syndromes and to use tumor-specific genetic aberrations to optimize treatment and monitoring of cancer patients.
Research group leader
prof. dr. Marjolijn Ligtenberg
Welcome to Research
We aim to optimize recognition of genetic tumor risk syndromes and to use tumor-specific genetic aberrations to optimize treatment and monitoring of cancer patients.
prof. dr. Marjolijn Ligtenberg